Press Releases

Date Title and Summary
Toggle Summary U.S. Government Purchases CyberKnife(R) System for Houston VA Hospital
First Government Contract Allows Greater Access to the Benefits of Radiosurgery SUNNYVALE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Government has purchased a CyberKnife(R) Robotic
Toggle Summary M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
SUNNYVALE, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company is partnering with The University of Texas M. D. Anderson Cancer Center in Houston, Texas to launch a prospective clinical study
Toggle Summary Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting
New CyberKnife Technologies Improve Treatment Times, Optimize Planning Objectives and Offer Increased Clinical Flexibility in Radiation Delivery SUNNYVALE, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today
Toggle Summary Accuray Enters Partnership with Still River Systems
Accuray to Provide Robotic Patient Positioning System for Lower Cost Proton Therapy Solution SUNNYVALE, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company has entered into a partnership with
Toggle Summary Accuray Reports Record Revenue in First Quarter of Fiscal 2008
Click here for PDF version of this release Record Quarterly Revenue of $48.6 Million Backlog Reaches Record Level of $642 Million SUNNYVALE, Calif., Nov. 7 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced financial results
Toggle Summary Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
More Than 40,000 Patients Treated with CyberKnife Radiosurgery Worldwide SUNNYVALE, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that its CyberKnife(R) Robotic Radiosurgery System has been used to treat
Toggle Summary Leading Russian Cancer Center Acquires CyberKnife(R) System
Acquisition Marks First Robotic Radiosurgery System in Russia, Expanding Patients' Cancer Treatment Options SUNNYVALE, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the N. N.
Toggle Summary Accuray Incorporated's CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
SUNNYVALE, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at Piper Jaffray's Health Care
Toggle Summary Shanghai's First CyberKnife(R) System Installed at Major Academic Oncology Center
Install Marks the Fifth System in China and 121st CyberKnife System Installation SUNNYVALE, Calif, Nov. 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Hua Shan Hospital in Shanghai has installed a CyberKnife(R)
Toggle Summary Accuray Incorporated Named as Technology Pioneer 2008 by the World Economic Forum
SUNNYVALE, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the World Economic Forum has selected Accuray as a Technology Pioneers for 2008. Technology Pioneers are companies that have been identified

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.